Your browser doesn't support javascript.
loading
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Patel, Shreyaskumar; von Mehren, Margaret; Reed, Damon R; Kaiser, Pamela; Charlson, John; Ryan, Christopher W; Rushing, Daniel; Livingston, Michael; Singh, Arun; Seth, Rahul; Forscher, Charles; D'Amato, Gina; Chawla, Sant P; McCarthy, Sharon; Wang, George; Parekh, Trilok; Knoblauch, Roland; Hensley, Martee L; Maki, Robert G; Demetri, George D.
Afiliação
  • Patel S; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • von Mehren M; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Reed DR; Moffitt Cancer Center, Tampa, Florida.
  • Kaiser P; Lutheran General Advanced Care Center, Park Ridge, Illinois.
  • Charlson J; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Ryan CW; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Rushing D; Simon Cancer Center, Indiana University, Indianapolis, Indiana.
  • Livingston M; Blumenthal Cancer Center, Carolinas HealthCare System, Charlotte, North Carolina.
  • Singh A; UCLA Medical Center, Los Angeles, California.
  • Seth R; SUNY Upstate University Hospital, Syracuse, New York.
  • Forscher C; Cedars-Sinai Medical Center, Los Angeles, California.
  • D'Amato G; Georgia Cancer Specialists, Northside Hospital Cancer Institute, Atlanta, Georgia.
  • Chawla SP; Sarcoma Oncology Center, Santa Monica, California.
  • McCarthy S; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Wang G; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Parekh T; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Knoblauch R; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Hensley ML; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Maki RG; Mount Sinai Medical Center, New York, New York.
  • Demetri GD; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts.
Cancer ; 125(15): 2610-2620, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31173362
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Dacarbazina / Trabectedina / Leiomiossarcoma / Lipossarcoma Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Dacarbazina / Trabectedina / Leiomiossarcoma / Lipossarcoma Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article